SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001753926-24-000545
Filing Date
2024-03-15
Accepted
2024-03-15 13:31:28
Documents
16
Period of Report
2024-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084127_8k.htm   iXBRL 8-K 34408
2 EXHIBIT 10.1 g084127_ex10-1.htm EX-10.1 41120
3 EXHIBIT 10.2 g084127_ex10-2.htm EX-10.2 57504
  Complete submission text file 0001753926-24-000545.txt   327906

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lipo-20240315.xsd EX-101.SCH 3012
5 XBRL LABEL FILE lipo-20240315_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE lipo-20240315_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT g084127_8k_htm.xml XML 3785
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 24753692
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)